Jinoos Yazdany
@jyazdanymd.bsky.social
Professor at UCSF, Chief of Rheumatology at SF General Hospital, using data analytics to improve the quality, safety, and equity of health care. Specialize in lupus.
The Navajo Nation, the largest Native American reservation, faces high prevalence of RA & shortage of rheumatology providers. A 12-week, culturally grounded telementorship program improved primary care providers' knowledge, confidence, & self-reported clinical behaviors in RA diagnosis & management
Improving RA care where it’s needed most. This study highlights a targeted training program for primary care providers on the Navajo Nation that builds capacity, expands access, and addresses disparities in rheumatology care. acrjournals.onlinelibrary.wiley.com/doi/10.1002/...
A Rheumatoid Arthritis Training Program for Primary Care Providers on the Navajo Nation
Objective The Navajo Nation, the largest Native American reservation, faces a high prevalence of rheumatoid arthritis (RA) and a critical shortage of rheumatology providers. To address this gap, we ...
acrjournals.onlinelibrary.wiley.com
What was the impact of the CVS formulary change preferring biosimilar adalimumab-adaz on prescribing in US community rheumatology practices? Arthritis Care & Research doi.org/10.1002/acr....
Thanks to noted futurist Jeff Goldsmith for his lovely and insightful review of A GIANT LEAP in today's Health Affairs journal. "... an island of calm and thoughtful commentary in the midst of an exhausting wave of hype.... Highly recommended." www.healthaffairs.org/content/fore...
A Voice Of Calm Amidst The AI Hype Storm | Health Affairs Forefront
Jeff Goldsmith reviews “A Giant Leap,” a thoughtful new book about how artificial intelligence is transforming health care, by Robert Wachter.
healthaffairs.org
Our recent work on sex differences in treatment discontinuation in axSpA. @jyazdanymd.bsky.social @rheumcat.bsky.social @nasingh.bsky.social
ACR Journals@acr-journals.bsky.social · 8mo agoRISE registry data were analyzed for trends in medication discontinuation by sex among patients with axSpA. Women with axSpA had a 24% & 25% higher risk of discontinuing TNFi & IL-17i than men with axSpA, but no sex differences were found for JAKi AC&R doi.org/10.1002/acr.... #Medsky
Thrilled to share our new paper comparing different LLMs to extract TNFi reasons and treatment trajectories from UCSF de-identified EHR data with @bmeow19.bsky.social, A. Garcia-Agundez and @jyazdanymd.bsky.social published in JAMIA open. academic.oup.com/jamiaopen/ar... @ucsf-bchsi.bsky.social
Cross-sectional study of adults with SLE in the US estimated 56.3% had polypharmacy (≥5 prescription or OTC meds). Arthritis Care & Research doi.org/10.1002/acr....
🎉 We're honored to present the Evelyn V. Hess Award to Dr. Karen Costenbader for advancing #lupus research and care, and the Mary Betty Stevens Prize to Dr. Andrea Fava for innovative research driving progress in lupus science. Learn more about their research: buff.ly/cn8xViK
Friends today but not tomorrow - come to the #ACR25 Great Debate Monday at 8:30 am on #AI in #Rheumatology!!!
Thrilled to see my book on healthcare Al available for preorder! sites.prh.com/preview/6f5c... I tried to cut through the hype, with stories & insights on everything from scribes to surgery, hallucinations to misinformation, med education to regulation. Plus "Will there be doctors?"@portfoliobooks
If the U.S. government wants to save $$$, they should read our article on #biosimilars: link.springer.com/article/10.1...
Breaking Barriers: Essential Reforms for a Competitive and Affordable Biosimilars Market - Current Rheumatology Reports
Purpose of review This update examines the current policy landscape for biosimilars, particularly those approved for treating rheumatoid arthritis. We review recent literature and recommend policies t...
link.springer.com
NEW Episode of the ACR Journals on Air podcast! 🎙️ Epidemiology meets clinical care—Laura Plantinga, PhD, shares insights from her research on #lupus & daily activity limitations 🎧 Listen → acr.tw/4dE1lHe Read the study → doi.org/10.1002/acr.... #Medsky
Miss the conversation on bias in healthcare AI? 🎥 Catch Paige Nong, @ajh.bsky.social, and @ryan-levi.bsky.social as they unpack real-world risks—and what it takes to evaluate AI tools responsibly. See how the experts broke it down: codex.ucsf.edu/events/codex... @tradeoffs.org
UCSF CODEX@ucsfcodex.bsky.social · last yr.🌟Register for CODEX's April webinar! What happens when AI tools in hospitals carry bias? And how can we prevent it? Join top researchers to talk about bias in health AI: what it looks like, who's testing for it, and what hospitals can do. 🗓️ April 30 | 9-10 a.m. PT 🔗 codex.ucsf.edu/events/codex...
Excellent career advice from Peter Hotez journals.plos.org/plosbiology/.... Also some good stuff here for universities to consider in the face of current challenges.
Navigating your US bioscience career into the 2030s
The coming decade might see major cuts to US Government funding for biomedicine and the mainstreaming of pseudoscience. This Perspective highlights how your biosciences PhD gives you the problem-solvi...
journals.plos.org
I’m excited to take on this new role and do my small smart to make sure AI is safe, fair, and effective. Best part is getting to work with visionary leaders like @julia-adler-mils.bsky.social @saramurray.bsky.social @sarahpollet.bsky.social and many others
UCSF DoC-IT@ucsfdocit.bsky.social · last yr.🚨 Big news in AI & healthcare! Jinoos Yazdany, MD, MPH, has been named Executive Director of AI Monitoring in Clinical Care at UCSF. She’ll lead efforts to ensure AI tools are evaluated and deployed safely and effectively. Read more: docit.ucsf.edu/news/jinoos-... @jyazdanymd.bsky.social
🚨 Big news in AI & healthcare! Jinoos Yazdany, MD, MPH, has been named Executive Director of AI Monitoring in Clinical Care at UCSF. She’ll lead efforts to ensure AI tools are evaluated and deployed safely and effectively. Read more: docit.ucsf.edu/news/jinoos-... @jyazdanymd.bsky.social
Somewhere in the U.S., there’s a scientist staring at their NSF/NIH grant application wondering why they bother. This post is for you. Science and society both need you. Hang in there and know there is a whole community supporting you.
Fantastic, super clear explanation by Dr. Choo of NIH grants process: takes “tens of thousands of reviewers annually on more than 1000 meetings with study sections like the one I should have been sitting in Thursday.” Even if/when the freeze ends, can’t just be restarted with a snap. 🧪
Esther Choo@choo.bsky.social · 2y agoAn explainer about how health research funding happens and why this NIH funding cycle shutdown matters: www.msnbc.com/opinion/msnb...
Health Disparities are real & lethal. Research on ⬇️ health disparities & improving health among impacted pops is critical. The NIMHD (NIH Institute that focuses on ⬇️ disparities) website remains. But if you search NIH Health Disparities, the page is gone. Chilling.
Extremely pleased to see this published! It takes a whole division of rheumatology to be on the look out for active SLE patients in the clinics/hospital with an active flare to enroll them in research and follow them over time clinicalepigeneticsjournal.biomedcentral.com/articles/10....
Changes in DNA methylation are associated with systemic lupus erythematosus flare remission and clinical subtypes - Clinical Epigenetics
Background Systemic lupus erythematosus (SLE) has numerous symptoms across organs and an unpredictable flare-remittance pattern. This has made it challenging to understand drivers of long-term SLE out...
clinicalepigeneticsjournal.biomedcentral.com
We have 2 fellowship positions available (1 pediatric rheumatology, 1 med-peds rheumatology) at the Children’s Hospital at Montefiore, Bronx, NY. We welcome #IMG and sponsor both J1 and H1b visas. You will never regret being part of this outstanding team! See information below if interested!
Dr. Jenny Mandal's Rheumatology Access Expansion (RAE: raeinitiative.org) has trained 111 primary care clinicians on Native American reservations around the U.S. to care for people with #RA. Read about her inspiring work at the link below. #rheumsky #UCSFrheum
This trial is very interesting - we need ways to prevent LN before it happens! Early MMF helps but for how long should rx continue? Also need to further define who will benefit. jamanetwork.com/journals/jam...
Mycophenolate Mofetil and New-Onset Systemic Lupus Erythematosus
This randomized clinical trial investigates whether early application of mycophenolate mofetil improves long-term outcomes in patients with newly diagnosed systemic lupus erythematosus with a high tit...
jamanetwork.com
#ACR24 Older patients, those in low nSES areas, and certain racial/ethnic groups less likely to get b/tsDMARDs, trends that did not change over last decade.#RISE-registry. www.heal.com/news/rheumat...
Age, racial gaps in b/tsDMARD use for rheumatoid arthritis show ‘surprising’ stability
WASHINGTON — Disparities in the use of biologic and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis, including among older, Black and Asian patients, have not c...
healio.com
For the second year, @ACRheum’s Global Engagement Committee along with @rheum_covid leaders were able to review over 60 applications and provide travel awards to these accomplished individuals to attend #ACR24
